Crossmark

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype

Crossref DOI link: https://doi.org/10.1038/s41416-023-02282-2

Published Online: 2023-05-17

Published Print: 2023-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aprile, Marianna

Cataldi, Simona

Perfetto, Caterina

Federico, Antonio https://orcid.org/0000-0003-2554-9879
Ciccodicola, Alfredo

Costa, Valerio https://orcid.org/0000-0002-7294-6933
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (23453)

Regione Campania (POR SATIN FESR)
License Information

Text and Data Mining valid from 2023-05-17

Version of Record valid from 2023-05-17
More Information

Article History

Received: 7 October 2022

Revised: 3 April 2023

Accepted: 14 April 2023

First Online: 17 May 2023

Competing interests

: The authors declare no competing interests.

: Not applicable.

: This manuscript has not been previously published and is not under consideration for publication elsewhere.

Document is current

Any future updates will be listed below